Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
As feeds become entertainment hubs, marketers rethink social’s role
As social platforms become entertainment hubs, brands are acting more like media companies to capture attention and drive sales.
How Olly is updating its product detail pages for the AI era
As more shoppers use AI chatbots for recommendations, supplement brand Olly is updating its product pages with clearer descriptions and FAQs to boost AI-driven sales.
In Graphic Detail: Why the best brands are relearning how to entertain first, advertise second
Read on to learn more about the factors driving that shift, in graphic detail.